listen anywhere

your storyflo · everywhere you listen.

Create private feed

Apple Podcasts Spotify YouTube Amazon Music iHeartRadio RSS feed

Platform Listeners Publishers Agents About

← Storyflo·FierceBiotech· biotech

All media tech finance sports science culture

biotech

<a href="https://www.fiercebiotech.com/biotech/boehringer-furthers-inflammatory-expansion-eu407m-biobuck-bet-immunitas-asset" hreflang="en">Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset</a>

FierceBiotech

May 12, 2026 · 22s listen

Listen · FierceBiotech

0:00-0:22

Live · Kokoro-82M

Audio pre-rendered by Storyflo · cached + delivered from the edge

Boehringer Ingelheim has put up 407.5 million euros in biobucks to secure global rights to a first‑in‑class antibody Immunitas Therapeutics is developing for chronic inflammatory and autoimmune diseases.

Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to FierceBiotech.

𝕏 Post on X in Share on LinkedIn ✉ Email a friend

Tip the publisher

Discussion

1500 characters left

Loading comments...

Heard via Storyflo

Get audio versions of every article you read.

Pick what matters — your audio curator gets you into your daily flo.

Join the listener waitlist

<a href="https://www.fiercebiotech.com/biotech/... · Storyflo